Nuveen Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-19,165
| Closed | -$174K | – | 3304 |
|
2023
Q1 | $174K | Sell |
19,165
-1,962
| -9% | -$17.8K | ﹤0.01% | 3008 |
|
2022
Q4 | $248K | Sell |
21,127
-2,844
| -12% | -$33.4K | ﹤0.01% | 3024 |
|
2022
Q3 | $508K | Sell |
23,971
-403
| -2% | -$8.54K | ﹤0.01% | 2960 |
|
2022
Q2 | $591K | Sell |
24,374
-1,424
| -6% | -$34.5K | ﹤0.01% | 2976 |
|
2022
Q1 | $1.2M | Buy |
25,798
+139
| +0.5% | +$6.47K | ﹤0.01% | 2740 |
|
2021
Q4 | $1.69M | Sell |
25,659
-1,824
| -7% | -$120K | ﹤0.01% | 2649 |
|
2021
Q3 | $2.73M | Buy |
27,483
+181
| +0.7% | +$18K | ﹤0.01% | 2527 |
|
2021
Q2 | $2.74M | Sell |
27,302
-1,806
| -6% | -$182K | ﹤0.01% | 2556 |
|
2021
Q1 | $2.72M | Buy |
29,108
+3,299
| +13% | +$308K | ﹤0.01% | 2463 |
|
2020
Q4 | $2.13M | Sell |
25,809
-1,103
| -4% | -$91K | ﹤0.01% | 2475 |
|
2020
Q3 | $2.31M | Sell |
26,912
-197
| -0.7% | -$16.9K | ﹤0.01% | 2306 |
|
2020
Q2 | $2.52M | Buy |
27,109
+5,804
| +27% | +$540K | ﹤0.01% | 2239 |
|
2020
Q1 | $607K | Buy |
21,305
+7,437
| +54% | +$212K | ﹤0.01% | 2701 |
|
2019
Q4 | $575K | Buy |
13,868
+6,522
| +89% | +$270K | ﹤0.01% | 2874 |
|
2019
Q3 | $104K | Hold |
7,346
| – | – | ﹤0.01% | 3167 |
|
2019
Q2 | $257K | Buy |
+7,346
| New | +$257K | ﹤0.01% | 3123 |
|